Abstract The worldwide CoVid-19 pandemic has led to an unprecedented push across the whole of scientific community develop a potent antiviral drug and vaccine as soon possible. Existing academic, governmental industrial institutions companies have engaged in large-scale screening existing drugs, vitro, vivo silico. Here, we are using silico modelling possible SARS-CoV-2 targets, deposited on Pr...